IP Library Granted Patent US 9,180,298
Granted Patent B2
US 9,180,298 · App. 14/163,149 · Granted Nov 10, 2015

Extended pain relief via high frequency spinal cord modulation, and associated systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,180,298
App. No.
14/163,149
Granted
Nov 10, 2015
Kind
B2
Abstract

Extended pain relief via high frequency spinal cord modulation, and associated systems and methods. A method for treating a patient in accordance with a particular embodiment includes selecting a neural modulation site to include at least one of a dorsal root entry zone and dorsal horn of the patient's spinal cord, and selecting parameters of a neural modulation signal to reduce patient pain for a period of time after ceasing delivery of the signals, the period of time being at least one tenth of one second.

Claims (49)

1. A method of treating pain in a patient, comprising:

applying to a dorsal horn of the patient a non-paresthesia-producing neural modulation signal having a signal frequency in a frequency range of from 1.5 kHz to 100 kHz, to thereby desensitize one or more wide dynamic range neurons in the dorsal horn.

2. The method of claim 1 wherein applying includes applying the neural modulation signal via an implanted signal delivery device.

3. The method of claim 2 , further comprising implanting the signal delivery device in the patient's epidural space.

4. The method of claim 1 wherein the neural modulation signal is, on a repeated basis, (a) automatically deactivated for a period of at least one second and (b) automatically reactivated at the conclusion of the period.

5. The method of claim 1 wherein the neural modulation signal is, on a repeated basis, (a) automatically deactivated for a period of at least one minute and (b) automatically reactivated at the conclusion of the period.

6. The method of claim 1 wherein the neural modulation signal is, on a repeated basis, (a) automatically deactivated for a period of at least one hour and (b) automatically reactivated at the conclusion of the period.

7. The method of claim 1 wherein the neural modulation signal is, on a repeated basis, (a) automatically deactivated for a period of at least one day and (b) automatically reactivated at the conclusion of the period.

8. The method of claim 1 wherein the neural modulation signal reduces neural transmissions entering the spinal cord at the patient's dorsal root, dorsal root entry zone, or both.

9. The method of claim 1 , further comprising implanting a signal delivery device in the patient's epidural space and applying the neural modulation signal to a target location without undergoing a trial and error mapping process to identify which, of multiple contacts carried by the signal delivery device, the neural modulation signal is to be directed to in order to apply the neural modulation signal to the target location.

10. The method of claim 1 , further comprising implanting a signal delivery device in the patient's epidural space and applying the neural modulation signal to a target location without undergoing a paresthesia mapping process to identify which, of multiple contacts carried by the signal delivery device, the neural modulation signal is to be directed to in order to apply the neural modulation signal to the target location.

11. The method of claim 1 wherein the frequency range is from 1.5 kHz to 50 kHz.

12. The method of claim 1 wherein the frequency range is from 3 kHz to 20 kHz.

13. The method of claim 1 wherein the frequency range is from 3 kHz to 15 kHz.

14. The method of claim 1 wherein the frequency range is from 5 kHz to 15 kHz.

15. The method of claim 1 wherein the frequency range is from 3 kHz to 10 kHz.

16. The method of claim 1 wherein the neural modulation signal has an amplitude in an amplitude range of from 0.1 mA to 20 mA.

17. The method of claim 1 wherein the neural modulation signal has an amplitude in an amplitude range of from 0.5 mA to 10 mA.

18. The method of claim 1 wherein the neural modulation signal has a pulse width in a pulse width range of from 10 microseconds to 333 microseconds.

19. The method of claim 1 wherein the neural modulation signal has a pulse width in a pulse width range of from 25 microseconds to 166 microseconds.

20. The method of claim 1 wherein the neural modulation signal has a pulse width in a pulse width range of from 33 microseconds to 100 microseconds.

21. The method of claim 1 wherein the neural modulation signal has a pulse width in a pulse width range of from 50 microseconds to 166 microseconds.

22. The method of claim 1 wherein the frequency range is from 5 kHz to 15 kHz, and wherein the signal has a pulse width in a pulse width range of from 10 microseconds to 333 microseconds, and wherein the signal has an amplitude in an amplitude range of 0.5 mA to 10 mA.

23. The method of claim 1 wherein the therapy is applied in sequential packets of pulses.

24. A method of treating pain in a patient, comprising:

applying to a dorsal horn of the patient a non-paresthesia-producing neural modulation signal having:

a signal frequency in a frequency range of from 5 kHz to 15 kHz,

a pulse width in a pulse width range of from 10 microseconds to 333 microseconds, and

an amplitude in an amplitude range of 0.5 mA to 10 mA,

to thereby desensitize one or more wide dynamic range neurons in the dorsal horn.

25. The method of claim 24 , further comprising implanting a signal delivery device in the patient's epidural space and applying the neural modulation signal to a target location without undergoing a trial and error mapping process to identify which, of multiple contacts carried by the signal delivery device, the neural modulation signal is to be directed to in order to apply the neural modulation signal to the target location.

26. The method of claim 24 , further comprising implanting a signal delivery device in the patient's epidural space and applying the neural modulation signal to a target location without undergoing a paresthesia mapping process to identify which, of multiple contacts carried by the signal delivery device, the neural modulation signal is to be directed to in order to apply the neural modulation signal to the target location.

27. A method of treating pain in a patient, comprising:

programming a pulse generator to generate a non-paresthesia-producing neural modulation signal having a signal frequency in a frequency range of from 1.5 kHz to 100 kHz; and

delivering the neural modulation signal to a dorsal horn of the patient via an implanted signal delivery device, thereby desensitizing one or more wide dynamic range neurons in the dorsal horn.

28. The method of claim 27 wherein the frequency range is from 5 kHz to 15 kHz, and wherein the neural modulation signal has a pulse width in a pulse width range of from 10 microseconds to 333 microseconds, and wherein the neural modulation signal has an amplitude in an amplitude range of 0.5 mA to 10 mA.

29. The method of claim 27 wherein the neural modulation signal is applied in sequential packets of pulses.

30. The method of claim 27 wherein the neural modulation signal is, on a repeated basis, (a) automatically deactivated for a period of at least one second and (b) automatically reactivated at the conclusion of the period.

31. The method of claim 27 wherein the frequency range is from 1.5 kHz to 50 kHz.

32. The method of claim 27 wherein the frequency range is from 3 kHz to 20 kHz.

33. The method of claim 27 wherein the frequency range is from 3 kHz to 15 kHz.

34. The method of claim 27 wherein the frequency range is from 5 kHz to 15 kHz.

35. The method of claim 27 wherein the frequency range is from 3 kHz to 10 kHz.

36. The method of claim 27 wherein the neural modulation signal has an amplitude in an amplitude range of from 0.1 mA to 20 mA.

37. The method of claim 27 wherein the neural modulation signal has an amplitude in an amplitude range of from 0.5 mA to 10 mA.

38. The method of claim 27 wherein the neural modulation signal has a pulse width in a pulse width range of from 10 microseconds to 333 microseconds.

39. The method of claim 27 wherein the neural modulation signal has a pulse width in a pulse width range of from 25 microseconds to 166 microseconds.

40. The method of claim 27 wherein the neural modulation signal has a pulse width in a pulse width range of from 33 microseconds to 100 microseconds.

41. The method of claim 27 wherein the neural modulation signal has a pulse width in a pulse width range of from 50 microseconds to 166 microseconds.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA NAME PREVIOUSLY RECORDED ON REEL 032039 FRAME 0324. ASSIGNOR(S) HEREBY CONFIRMS THE RECEIVING PARTY DATA NAME IS NEVRO CORP. Recorded Dec 8, 2016
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.
To: NEVRO CORP.
Reel/Frame 040854/0125 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT AGREEMENT (REAFFIRMATION) Recorded Jun 13, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC,
Reel/Frame 038984/0865 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2014
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.
To: NEVRO CORPORATION
Reel/Frame 032039/0324 →